دورية أكاديمية
Reasonable access: important characteristics and perceived quality of legal and illegal sources of cannabis for medical purposes in Canada.
| العنوان: | Reasonable access: important characteristics and perceived quality of legal and illegal sources of cannabis for medical purposes in Canada. |
|---|---|
| المؤلفون: | Capler NR; School of Population and Public Health, Faculty of Medicine, University of British Columbia, 2206 East Mall, Musqueam Traditional Territory, Vancouver, BC, V6T 1Z3, Canada. rielle@telus.net., Balneaves LG; College of Nursing, University of Manitoba, Room 495, 89 Curry Place, Winnipeg, MB, R3T 2N2, Canada., Buxton JA; School of Population and Public Health, Faculty of Medicine, University of British Columbia, 2206 East Mall, Musqueam Traditional Territory, Vancouver, BC, V6T 1Z3, Canada.; British Columbia Centre for Disease Control, 655 West 12th Avenue, Vancouver, BC, V5Z 4R4, Canada., Kerr T; British Columbia Centre on Substance Use, 400-1045 Howe Street, Vancouver, BC, V6Z 2A9, Canada.; Department of Medicine, University of British Columbia, St. Paul's Hospital, 608-1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada. |
| المصدر: | Journal of cannabis research [J Cannabis Res] 2023 Jun 09; Vol. 5 (1), pp. 18. Date of Electronic Publication: 2023 Jun 09. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101752723 Publication Model: Electronic Cited Medium: Internet ISSN: 2522-5782 (Electronic) Linking ISSN: 25225782 NLM ISO Abbreviation: J Cannabis Res Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: [London] : BioMed Central Ltd., [2019]- |
| مستخلص: | Background: Throughout the past two decades of legal medical cannabis in Canada, individuals have experienced challenges related to accessing legal sources of cannabis for medical purposes. The objective of our study was to examine the sources of cannabis accessed by individuals authorized to use medical cannabis and to identify possible reasons for their use of illegal sources. Methods: Individuals who participated in the Cannabis Access Regulations Study (CANARY), a national cross-sectional survey launched in 2014, and indicated they were currently authorized to use cannabis for medical purposes in Canada were included in this study. We assessed differences between participants accessing cannabis from only legal sources versus from illegal sources in relation to sociodemographic characteristics, health-related factors, and characteristics of medical cannabis they considered important. A secondary analysis assessed differences in satisfaction with various dimensions of cannabis products and services provided by legal versus illegal sources. Results: Half of the 237 study participants accessed cannabis from illegal sources. Individuals accessing cannabis from illegal sources were significantly more likely to value pesticide-free products, access to a variety of strains, ability to select strain and dosage, ability to observe and smell cannabis, availability in a dispensary, and availability in small quantities than did individuals accessing cannabis from only legal sources (all p < 0.05). Additionally, participants gave significantly higher satisfaction scores to illegal sources than to legal sources on service-related dimensions of cannabis access (all p < 0.05). Conclusion: Our findings contribute to an understanding of reasonable access to medical cannabis from a patient perspective and how to assess whether it has been achieved. Characteristics of cannabis products and services valued by patients and appropriate to their needs should be incorporated into legal medical cannabis programs to promote the use of legal medical sources. While pertaining specifically to medical use of cannabis in Canada, the findings of this study may also be instructive for understanding the use of illegal cannabis sources for non-medical purposes in Canada and provide insight for other jurisdictions implementing cannabis regulations for both medical and non-medical purposes. (© 2023. The Author(s).) |
| References: | J Health Soc Behav. 1995 Mar;36(1):1-10. (PMID: 7738325) Int J Drug Policy. 2018 Feb;52:62-70. (PMID: 29247863) Planta Med. 2018 Mar;84(4):225-233. (PMID: 29161743) PLoS One. 2015 Aug 26;10(8):e0133292. (PMID: 26308334) J Toxicol Sci. 2015 Dec;40(6):797-803. (PMID: 26558460) Int J Equity Health. 2021 May 7;20(1):116. (PMID: 33962627) Subst Use Misuse. 2011;46(6):769-80. (PMID: 21138343) Int J Drug Policy. 2013 Nov;24(6):511-6. (PMID: 24095000) BMC Public Health. 2022 Feb 21;22(1):368. (PMID: 35189856) Nurs Outlook. 2005 Nov-Dec;53(6):274-80. (PMID: 16360698) Drugs (Abingdon Engl). 2020;27(1):69-78. (PMID: 31949332) Int J Drug Policy. 2021 Feb;88:103035. (PMID: 33310342) Drug Test Anal. 2020 Feb;12(2):180-190. (PMID: 31834671) Harm Reduct J. 2023 Feb 17;20(1):19. (PMID: 36803833) Cannabis Cannabinoid Res. 2016 Jun 01;1(1):131-138. (PMID: 28861489) Br J Clin Pharmacol. 2018 Nov;84(11):2468-2476. (PMID: 29953631) BMC Public Health. 2022 Nov 8;22(1):2048. (PMID: 36348479) Med Cannabis Cannabinoids. 2020 Jan 15;3(1):76-83. (PMID: 34676342) Drug Alcohol Rev. 2020 May;39(4):337-346. (PMID: 32291811) J Affect Disord. 2018 Aug 1;235:198-205. (PMID: 29656267) JAMA Netw Open. 2021 Sep 1;4(9):e2124511. (PMID: 34524435) Br J Pharmacol. 2011 Aug;163(7):1344-64. (PMID: 21749363) Harm Reduct J. 2006 Nov 13;3:32. (PMID: 17101054) Harm Reduct J. 2022 Jul 30;19(1):88. (PMID: 35907959) Med Care. 1981 Feb;19(2):127-40. (PMID: 7206846) Health Econ Policy Law. 2009 Apr;4(Pt 2):179-93. (PMID: 19187569) Harm Reduct J. 2012 Jan 03;9:2. (PMID: 22214382) Int J Drug Policy. 2014 Jul;25(4):691-9. (PMID: 24947993) Sci Rep. 2021 Apr 15;11(1):8232. (PMID: 33859287) Biochem Pharmacol. 2018 Nov;157:285-293. (PMID: 29940172) Int J Equity Health. 2013 Mar 11;12:18. (PMID: 23496984) Patient Educ Couns. 2011 Jun;83(3):345-51. (PMID: 21440405) Adv Pharmacol. 2017;80:67-134. (PMID: 28826544) J Health Serv Res Policy. 2002 Jul;7(3):186-8. (PMID: 12171751) Int J Drug Policy. 2017 Sep;47:1-8. (PMID: 28667878) Cult Med Psychiatry. 2013 Sep;37(3):488-504. (PMID: 23820755) |
| فهرسة مساهمة: | Keywords: Access to healthcare; Cannabis; Cannabis products and services; Legal and illegal cannabis sources; Medical cannabis; Reasonable access |
| تواريخ الأحداث: | Date Created: 20230608 Latest Revision: 20230612 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC10251568 |
| DOI: | 10.1186/s42238-023-00185-w |
| PMID: | 37291647 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 2522-5782 |
|---|---|
| DOI: | 10.1186/s42238-023-00185-w |